We are today announcing two significant community-led scientific projects, both requiring the contributions of patients suffering Post-Finasteride Syndrome and the persistent conditions caused by use of isotretinoin (accutane), dutasteride (avodart) and saw palmetto (other 5 alpha reductase inhibiting substances) as well as SSRI class antidepressants and leuprorelin (lupron). Please read on for details of these initiatives and how you can help.
We are working together with the administrators of PSSD forum to conduct a Genome-wide association study (GWAS) across patient groups based on the SNP data provided with the DTC genetic testing service 23andme. We will be using high powered software and computing resources to perform a research project executed at the community level. We are hoping to identify associated SNPs, and possibly observe similarities between those suffering the respective conditions at the genomic level. It is hoped that this information will help us and our scientists better understand possible underlying genetic susceptibilities that could contribute to development of these syndromes. This is in contrast to the majority of people therapeutically using these substances who do not suffer persistent and devastating health problems following cessation. If statistical analysis of symptomatic vs control data sets reveals interesting findings, we will endeavour to work with one or more scientists to help us deepen our investigation and publish the results in a peer reviewed journal.
To achieve this, we need your help. If you already have taken a 23andMe test in the past, please click here for instructions on how to obtain your raw data. If you have not taken a 23andme test and would like to contribute your personal data to our project, please consider ordering a 23andme at-home saliva sample kit from their website. The cheaper ancestry option is sufficient as we require the raw data file, which is identical with either product offered.
Once you have downloaded and extracted the raw text file, please rename the file before submitting including your forum username and substance taken in the following way:
Examples would be as follows:
This will help us track which users have submitted data and their respective conditions.
Once your file is named appropriately, please submit your raw data file (once) via this link. By submitting your data, you consent to the use of the data for the aforementioned purposes.
In conjunction with the various patient communities, we are soon going to be launching a comprehensive cross-drug survey here on propeciahelp. This will consist of a questionnaire regarding your individual condition and symptoms following use of one of the previously specified substances. We will post the link to this when it is finalised. The survey has the following aims:
- Despite around 40 publications, the wide ranging and systemic symptom profile of PFS has not yet been accurately characterised. This is also the case for the persistent disorders caused by antidepressants and accutane. We hope to achieve this through this project.
- While these syndromes have ostensible similarities, this will allow better data-driven analysis of the symptomatic overlap in the conditions.
- This survey will allow phenotypic profiling of the variable conditions experienced by sufferers.
- In possible conjunction with our 23andme GWAS, we aim to have a scientific publication following completion and analysis of an adequate volume of submissions from each of the affected groups.
We are currently implementing technology to tie this to your propeciahelp forum account, with the intention that you should be able to click through to the survey and it will link to your user profile. Members from each community have given valuable input into the survey and it has been refined over several months. However, if you have feedback that you think we may have not taken into account and would like us to consider then please send a private message to @axolotl, @awor or @ghost on the propeciahelp forum with your thoughts.
We believe this profiling is overdue and will be a highly significant milestone for our respective conditions. Your submissions of 23andme raw data and your time spent filling out the survey once it is published will be greatly appreciated and hopefully contribute to collective progress in understanding these syndromes.
We will keep you updated regarding these ongoing projects on the discussion forum.
Thank you for your ongoing support and courage